Charles Street Securities (CSS) Europe LLP

www.charlesstreetsecurities.co.uk

Foreign Investment Company

Tech Verticals Preferences

Automotive, Biotechnology, Broadcasting, Data Analytics, Digital Health, Digital Media, e-Commerce, eLearning, Enterprise Applications, Entertainment, Environment, FinTech, Hardware, Healthtech, Industrial Technologies, Materials, Medical Devices, MedTech, Mobile Applications, Online Advertising, SaaS, Security, WaterTech

General Data

Established	1984
Current Active Portfolio Companies:	3

DESCRIPTION

Charles Street Securities Europe LLP (CSS Europe) is authorized and regulated by the Financial Conduct Authority in the UK.

The firm manages the CSS Alpha Fund AIFLNP V.C.I.C. Ltd

CONTACT INFO

Expand / Collapse All

Main Address: London, United Kingdom

Address	1 Wilton Crescent St.
City	London
Country	United Kingdom
Zip	SW1X 8RN

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Gerard Mizrahi	Managing Partner & CEO

Preferences

Maximum investments	$2.5m
Minimum investments	$0.633m
Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Cleantech

67%

Biomed

33%

	PORTFOLIO COMPANIES

Current Portfolio Companies (3)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Akari

Biomed

PIPE	21/09/2015	N/A	$75m
PIPE	18/09/2013	N/A	$12.5m
Second Round	10/05/2007	N/A	$3.1m
First Round	08/06/2005	N/A	$4.1m

Greenkote

Cln.

PIPE

01/11/2005

N/A

$0.8m

Mapal

Cln.

Third Round	01/02/2016	N/A	$0.64m
Second Round	07/05/2013	$2m	$2.3m
First Round	24/11/2010	$2.45m	$2.45m

Exits (4)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij (Other)	Holdings Sold		abCDe
abC Defghij	IPO	23/12/2010	abCDe
abC Defghij	Acquired	10/06/2018	abCDe
abC Defghij	IPO	19/08/2004	abCDe

Historic Portfolio (3)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

MIRAS

Ceased to Operate

Second Round

01/09/2004

$2m

Sepal Pharma

Ceased to Operate

Biomed

First Round	13/06/2006	$2.6m	$4m
Seed	01/01/2004	N/A	$5.2m	Holds 7.23% of the company; Total round was $5.2m

TKsignal

Ceased to Operate

Biomed

First Round - Extended

25/06/2006

$1.3m

$2.5m

Last Updated:	abCDe
IVC Number:	abCDe